Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-25-040776
Filing Date
2025-03-18
Accepted
2025-03-18 08:10:14
Documents
2
Period of Report
2025-03-18

Document Format Files

Seq Description Document Type Size
1 6-K 6-k_clinical_study_enrol.htm 6-K 26704
2 EX-99.1 vrax-ex99_1.htm EX-99.1 11427
  Complete submission text file 0000950170-25-040776.txt   39344
Mailing Address BIOCITY GLASGOW BO'NESS ROAD, NEWHOUSE LANARKSHIRE X0 ML1 5UH
Business Address BIOCITY GLASGOW BO'NESS ROAD, NEWHOUSE LANARKSHIRE X0 ML1 5UH 44 020 7788 7414
Virax Biolabs Group Ltd (Filer) CIK: 0001885827 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-41440 | Film No.: 25746545
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)